Core Viewpoint - Dr Martens reported a decline in quarterly sales and forecasted flat annual revenue growth due to weak demand and higher import costs, leading to a nearly 13% drop in shares [1][2]. Sales Performance - Revenue fell by 3.1% to £251 million ($343 million), with direct-to-consumer sales decreasing by 7% for the third quarter ending December 28 [2]. - The Americas region experienced a 2% revenue growth on a constant currency basis, as U.S. consumers were more receptive to the full-price strategy compared to Europe and Asia-Pacific [3]. Consumer Behavior - Cost-conscious consumers in Europe, particularly in Germany and the UK, avoided non-discounted products, while affluent shoppers in the U.S. increased spending during the holiday season [4]. - The company noted that newer and more expensive boots were performing well in the U.S. market [4]. Strategic Outlook - CEO Ije Nwokorie is focusing on reducing promotions and discounts to protect margins, despite the challenges in predicting near-term demand for boots [2][3]. - The company is expanding into new markets in Latin America, including Colombia and Uruguay, while maintaining its forecast for significant profit growth for the year ending March [5].